Cargando…
Response of human melanoma cell lines to interferon-beta gene transfer mediated by a modified adenoviral vector
Since melanomas often retain wild type p53, we developed an adenoviral vector, AdRGD-PG, which provides robust transduction and transgene expression in response to p53. Previously, this vector was used for interferon-β gene transfer in mouse models of melanoma, resulting in control of tumor progress...
Autores principales: | David, Taynah I. P., Cerqueira, Otto L. D., Lana, Marlous G., Medrano, Ruan F. V., Hunger, Aline, Strauss, Bryan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578831/ https://www.ncbi.nlm.nih.gov/pubmed/33087767 http://dx.doi.org/10.1038/s41598-020-74826-y |
Ejemplares similares
-
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
por: Hunger, Aline, et al.
Publicado: (2017) -
Improving adenoviral vectors and strategies for prostate cancer gene therapy
por: Tamura, Rodrigo Esaki, et al.
Publicado: (2018) -
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
por: Hunger, Aline, et al.
Publicado: (2017) -
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
por: Medrano, Ruan F. V., et al.
Publicado: (2022) -
Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
por: Strauss, Bryan E, et al.
Publicado: (2018)